ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Calcineurin"

  • 2021 American Transplant Congress

    A Comparison of Belatacept Conversion Regimens from Calcineurin Inhibitor-Based Immunosuppression

    E. Huang, A. Vo, A. Peng, R. Najjar, S. Sethi, S. Jordan

    Cedars-Sinai Medical Center, Los Angeles, CA

    *Purpose: Outcomes with varying belatacept conversion protocols from calcineurin inhibitor (CNI)-based immunosuppression have been published but no standard protocol has been established. Beginning in 2012,…
  • 2021 American Transplant Congress

    Higher Calcineurin Inhibitor Levels Associate with Graft Outcomes in Kidney Recipients with De Novo Donor-specific Antibodies of Either Hla Class I or II

    M. Béland, S. De Serres

    Nephrology, CHU de Québec- Université Laval, Québec, QC, Canada

    *Purpose: The development of de novo anti-HLA donor specific antibodies (dnDSA) is associated with poorer outcomes in kidney transplant recipients. We and other previously reported…
  • 2021 American Transplant Congress

    Evaluation of the Conversion from Tacrolimus to Sirolimus in Liver Transplant Recipients

    H. Bakhtiari1, S. Todd2, H. Snyder2, D. Lo2, M. Flynn2

    1Mercer University College of Pharmacy, Atlanta, GA, 2Emory University Hospital, Atlanta, GA

    *Purpose: The purpose of this study was to compare outcomes in liver transplant patients maintained on standard calcineurin inhibitor (CNI) therapy with tacrolimus versus those…
  • 2021 American Transplant Congress

    Early Reduction of Tacrolimus Trough Levels Improves Long-term Kidney Function without Increase in Incidence of Acr

    M. Chen1, B. Loza1, A. Chang1, R. Byfield2, K. Olthoff1, A. Shaked1

    1Department of Surgery, University of Pennsylvania, Philadelphia, PA, 2Data Analytics Center, Penn Medicine Information Systems, University of Pennsylvania Health System, Philadelphia, PA

    *Purpose: We examined the impact of clinical practice management of tacrolimus trough levels in liver transplant recipients on kidney function and incidence of rejection in…
  • 2021 American Transplant Congress

    Quantifying the Interaction Between Posaconazole and Tacrolimus in Liver Transplant Recipients: A Practical Approach

    B. Lane1, U. Kaszubski1, A. Freeman1, B. Wise1, L. Hutchinson1, M. Janusek1, G. Therapondos2, H. Bohorquez3, S. Anders1

    1Pharmacy, Ochsner Medical Center, New Orleans, LA, 2Hepatology, Ochsner Medical Center, New Orleans, LA, 3Transplant Surgery, Ochsner Medical Center, New Orleans, LA

    *Purpose: The interaction between tacrolimus (FK) and posaconazole (POSA) is well documented, however the extent of this interaction and the practical management has yet to…
  • 2021 American Transplant Congress

    Systematic Evaluation of Immunosuppressant Drug Tolerability in Lung Transplant Recipients with Short Telomere Syndrome

    R. Patolia1, R. Guzy2, L. Potter1

    1Department of Pharmacy, University of Chicago Medicine, Chicago, IL, 2Department of Medicine, Division of Pulmonology, University of Chicago Medicine, Chicago, IL

    *Purpose: Lung transplant recipients with short telomere syndrome are at high risk of hematologic complications. Consequently, patients with short telomere syndrome may require more frequent…
  • 2021 American Transplant Congress

    Unclear Implications of Tacrolimus Time in Therapeutic Range as a Predictor of Acute Rejection in Renal Transplant Recipients Undergoing Early Corticosteroid Withdrawal

    D. Pierce, P. West-Thielke, Z. Hajjiri, S. Gaitonde, I. Tzvetanov, E. Benedetti, A. Lichvar

    University of Illinois at Chicago, Chicago, IL

    *Purpose: Tacrolimus (TAC) demonstrates a wide intra- and inter-patient variability (IPV) necessitating therapeutic drug monitoring. The purpose of this study is to determine the impact…
  • 2020 American Transplant Congress

    MTOR-Inhibitor Regimens and Malignancy after Kidney Transplantation: Can the Risk Be Modified by Considering Human Leukocyte Antigen (HLA) Mismatch in Immunosuppression Selection?

    A. Santos1, C. Chen1, K. Alquadan2, M. A. Leghrouz2, X. Wen3

    1University of Florida, Gainesville, FL, 2Division of Nephrology, Hypertension, & Renal Transplantation, University of Florida, Gainesville, FL, 3Department of Pharmacy Practice, University of Rhode Island, Kingston, RI

    *Purpose: We investigated the outcomes of mammalian target of rapamycin inhibitor (MTORI) regimens in adult kidney transplant (KT) recipients (KTRs) in categories of donor/recipient pre-transplant…
  • 2020 American Transplant Congress

    Steroids Ameriplate the Progression of Calcineurin Inhibitors Nephrotoxicity in Kidney Allografts

    N. Iwahara1, H. Sasaki2, D. Iwami1, K. Hotta1, Y. Takada1, H. Higuchi2, T. Tanabe2, N. Shinohara1

    1Hokkaido University, Sapporo, Japan, 2Sapporo City General Hospital, Sapporo, Japan

    *Purpose: Although calcineurin inhibitors (CNI) lead to excellent short-term kidney allograft outcome, chronic nephrotoxicity is a major concern which affects long-term allograft survival. It has…
  • 2020 American Transplant Congress

    Impact of CYP3A5 Phenotype on Early Time in Therapeutic Range among Pediatric Renal and Heart Transplant Recipients

    A. Leino, A. Pasternak

    University of Michigan, Ann Arbor, MI

    *Purpose: Tacrolimus time in therapeutic range (TTR) as a measure of intra-patient variability has been associated with poor long-term outcomes. Multiple factors may contribute to…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 16
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences